Cargando…
Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357535/ https://www.ncbi.nlm.nih.gov/pubmed/34401149 http://dx.doi.org/10.1002/cti2.1331 |
| _version_ | 1783737148942319616 |
|---|---|
| author | Brown, Michael P Ebert, Lisa M Gargett, Tessa |
| author_facet | Brown, Michael P Ebert, Lisa M Gargett, Tessa |
| author_sort | Brown, Michael P |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8357535 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83575352021-08-15 Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma Brown, Michael P Ebert, Lisa M Gargett, Tessa Clin Transl Immunology Corrigendum John Wiley and Sons Inc. 2021-08-11 /pmc/articles/PMC8357535/ /pubmed/34401149 http://dx.doi.org/10.1002/cti2.1331 Text en © 2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Corrigendum Brown, Michael P Ebert, Lisa M Gargett, Tessa Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma |
| title | Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma |
| title_full | Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma |
| title_fullStr | Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma |
| title_full_unstemmed | Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma |
| title_short | Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma |
| title_sort | clinical chimeric antigen receptor t‐cell therapy: a new and promising treatment modality for glioblastoma |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357535/ https://www.ncbi.nlm.nih.gov/pubmed/34401149 http://dx.doi.org/10.1002/cti2.1331 |
| work_keys_str_mv | AT brownmichaelp clinicalchimericantigenreceptortcelltherapyanewandpromisingtreatmentmodalityforglioblastoma AT ebertlisam clinicalchimericantigenreceptortcelltherapyanewandpromisingtreatmentmodalityforglioblastoma AT gargetttessa clinicalchimericantigenreceptortcelltherapyanewandpromisingtreatmentmodalityforglioblastoma |